Aligos Therapeutics
ALGS
ALGS
71 hedge funds and large institutions have $390M invested in Aligos Therapeutics in 2021 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 23 increasing their positions, 16 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
0.16% more ownership
Funds ownership: 2.93% → 3.09% (+0.16%)
19% less capital invested
Capital invested by funds: $484M → $390M (-$93.6M)
Holders
71
Holding in Top 10
4
Calls
$183K
Puts
–
Top Buyers
| 1 | +$13.7M | |
| 2 | +$13.4M | |
| 3 | +$4.26M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.18M |
| 5 |
EC
EcoR1 Capital
San Francisco,
California
|
+$1.08M |
Top Sellers
| 1 | -$4.96M | |
| 2 | -$3.87M | |
| 3 | -$3.17M | |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$1.73M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$1.59M |